99011-02-6
99011-02-6
Chemical Structure
Imiquimod
Synonym(s): R 837
- CAS No.: 99011-02-6
- Formula:C14H16N4
- Molecular Weight:240.30
IUPAC Name: 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
InChIKey: DOUYETYNHWVLEO-UHFFFAOYSA-N
SMILES: NC1=NC2=CC=CC=C2C3=C1N=CN3CC(C)C
Biological Activity: Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Imiquimod | 99.97% | Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Imiquimod (Standard) | ≥98% | Imiquimod (Standard) is the analytical standard of Imiquimod. This product is intended for research and analytical applications. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Imiquimod-d7 | Imiquimod-d7 (R 837-d7) is deuterium labeled Imiquimod. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Imiquimod-d9 | Imiquimod-d9 is deuterium labeled Imiquimod. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Imiquimod-d6 | Imiquimod-d6 is the deuterium labeled Imiquimod. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
